The European Biotech Act is a law that simplifies rules for biotech, helps companies get money and skills, and keeps products safe, so the EU can grow its biotech industry faster and more securely.

The resolution updates EU medical device safety rules to make them less expensive and time-consuming for companies while keeping devices safe, so patients can get the medical equipment they need faster and small companies won't go out of business trying to follow complicated requirements.

The European Biotech Act is a new rule that speeds up approvals, brings more money, and cuts red‑tape so EU biotech companies can develop and sell medicines and foods faster.

The EU decision updates Finland’s Recovery and Resilience Plan, keeping the same EU money but changing 53 measures and milestones to match new conditions, so Finland can still reach its climate and tech targets.

This resolution revamps the Research Fund for Coal and Steel, giving it a €200 million yearly budget, two funding calls a year, full support for SMEs, clearer rules, and tighter alignment with the EU’s clean‑energy goals.

The EU is adopting a new Council Decision that replaces the old rules for the Research Fund for Coal and Steel, giving it a €200 million yearly budget, simplifying applications, using leftover assets to fund research, and letting the Commission adjust how much goes to coal versus steel to help both industries shift to low‑carbon production.

This new EU regulation merges old rules, creates a digital system to license and track dangerous chemicals, bans designer precursors unless licensed, and cuts paperwork for businesses.